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In the present paper, we describe the facts that took place in the rat brain after a single
injection of the enzyme neuraminidase from Clostridium perfringens into the right lateral
ventricle. After injection, it diffused through the cerebrospinal fluid of the ipsilateral ven-
tricle and the third ventricle, and about 400µm into the periventricular brain parenchyma.
The expression of ICAM1 in the endothelial cells of the periventricular vessels, IBA1 in
microglia, and GFAP in astrocytes notably increased in the regions reached by the injected
neuraminidase. The subependymal microglia and the ventricular macrophages begun to
express IL1β and some appeared to cross the ependymal layer. After about 4 h of the injec-
tion, leukocytes migrated from large venules of the affected choroid plexus, the meninges
and the local subependyma, and infiltrated the brain. The invading cells arrived orderly:
first neutrophils, then macrophage-monocytes, and last CD8α-positive T-lymphocytes and
B-lymphocytes. Leukocytes in the ventricles and the perivascular zones penetrated the
brain parenchyma passing through the ependyma and the glia limitans.Thus, it is likely that
a great part of the damage produced by microorganism invading the brain may be due to
their neuraminidase content.
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INTRODUCTION
In agreement to Graeber et al. (1) the term neuroinflammation
implies not only microglial activation but also the invasion of
the nervous tissue and/or the cerebrospinal fluid (CSF) by blood-
circulating leukocytes. Inflammation of the brain can be triggered
by the presence in the ventricle, the meninges, or the nervous
parenchyma of biological agents such as bacteria or viruses, or
by a plethora of chemical or mechanical stimuli (2–5). In any
case, the clinical relevance of brain inflammation lies in part
on the detrimental or even lethal effects of the invading defen-
sive cells or proteins, which eventually can give rise to chronic
neurodegenerative diseases (6, 7).
Among the many agents that trigger neuroinflammation some
are located in the microbial envelope, such as lipopolysaccha-
rides (8, 9) or the enzyme neuraminidase (NA) (10). Indeed, the
abundance of NA in the outer surface of certain viruses and bac-
teria has been related to their pathogenicity (2, 11–14). So much
so that a single mutation in the hemagglutinin-NA (HN) sur-
face complex of the mump virus is enough as to greatly decrease
its pathogenicity, an interesting feature in the design of vaccines
(15). Moreover, inhibitors of the NA activity are among the most
important antiviral compounds [i.e., oseltamivir; (16)]. Despite all
evidences supporting a pre-eminent role of NA in neuroinflam-
mation, little is known about its exact mechanism of action and
the events that are triggered after its administration. Moreover,
the molecular differences among the neuraminidases that can be
found in the microbial covers, probably lead to differences in the
pathogenesis that they provoke (17).
Clostridium perfringens is a ubiquitous bacterium that possesses
NA at its surface (18). NA from C. perfringens is easily available, so
we used it before to desialylate some molecules present in the ven-
tricular CSF (19). We reported that a single intracerebroventricular
(ICV) injection of a high dose of NA (about 10µg) produced
the massive loss of the multiciliated ependyma followed by acute
inflammation of meninges and ventricles and the development
of hydrocephalus (10). By decreasing the amount of injected NA,
only a partial detachment of the ependymal layer occurred in the
injected lateral ventricle, but not in the contralateral ventricle or
the third ventricle. This model turned also useful to investigate
the importance of the ependyma on postnatal neurogenesis (20).
We investigated the time course of inflammatory events after ICV
administration of low doses of NA from C. perfringens, what might
prove to be a useful model to study neuroinflammation. The facts
suggest the importance of NA in degenerative events known to
occur after microbial invasion of the central nervous system.
MATERIALS AND METHODS
ANIMALS
Eighty-four adult male Wistar rats (body weight, bw, 250–300 g)
were used in this study (Charles River Laboratories, Barcelona,
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Spain). All animals were housed under a 12 h light/dark cycle with
food and water available ad libitum. Animal procedures were done
according to the European Union (86/609/EEC) and Spanish (RD
1201/2005) legislations.
INTRACEREBROVENTRICULAR INJECTION
Animals were anesthetized with 2,2,2-tribromoethanol (0.2 g/kg
body weight, Fluka Chemika, St. Louis, MO, USA) and positioned
in a stereotaxic frame. NA from C. perfringens (Roche Diagnos-
tics, Basel, Switzerland, catalog No. 11 585 886 001) dissolved in
0.9% sterile saline (25 mU/µl) was administrated by stereotaxic
surgery into the right lateral cerebral ventricle, in the following
coordinates from Bregma: antero-posterior=−0.5 mm; medio-
lateral=−1.4 mm; dorso-ventral=−3.5 mm (21). With the aid
of a pump, a 500 mU (20µl) of NA were injected at a rate of
2µl/min during 10 min. Control rats were injected with saline.
Some animals were sacrificed immediately after NA injection (time
0 h), and the rest were recovered from anesthesia and sacrificed
at 2, 4, 12, 24 h, 2, 4, 7, 15, 30 days, 3, and 6 months after the
administration of NA.
HISTOLOGICAL PROCEDURES
Animals were anesthetized with 2,2,2-tribromoethanol and tran-
scardially perfused with saline followed by Bouin’s fixative. Brains
were removed and immersed in the same fixative for 24 h at room
temperature (RT), and later embedded in paraffin wax. Seven-
micrometer sections were obtained from each brain, and series
along the region of interest (from Bregma −0.3 to −1.2 mm
approximately) were mounted in gelatine treated slides.
LECTIN BINDING
The Limax flavus agglutinin (LFA, Calbiochem, San Diego, CA,
USA) was chosen for its exclusive affinity for sialic acid. Deparaf-
finized thin sections were incubated with 4µg/ml LFA in lectin
buffer (1 mM Cl2Ca, 1 mM Cl2Mg, 0.6% TRIS, pH 7.6) for 1 h at
RT. The lectin bound to the tissue was later identified using a rabbit
anti-LFA antibody [(22); see Immunohistochemistry]. The peanut
(Arachis hypogea) agglutinin (PNA, Vector, Burlingame, CA, USA.
l-1070) has affinity for terminal residues of galactose, which
is the subterminal sugar residue in complex-type glycoproteins.
After the removal of terminal sialic acid, galactose is exposed as
terminal residue, and the PNA binding sites arise. To check for the
removal of sialic acid by the action of NA, sections were incubated
in 3µg/ml peroxidase-labeled PNA in 0.1 M phosphate buffered
saline (PBS) for 1 h at RT. The peroxidase activity was detected with
0.1 M PBS containing 0.05% diaminobenzidine (DAB; Sigma) and
0.03% hydrogen peroxide (Merck).
IMMUNOHISTOCHEMISTRY
Immunohistochemistry was carried out on deparaffinized tissue
sections using either immunoperoxidase or immunofluorescence
techniques. The primary and secondary antibodies used are listed
in Tables 1 and 2, respectively. All of them were diluted with PBT
buffer (0.3% bovine serum albumin, 0.3% Triton X-100 in PBS pH
7.3). Primary antibodies were incubated overnight at RT. Negative
controls for the immunostaining consisted in equivalent sections
subjected to the same protocol but omitting the primary antibody.
Sections for immunoperoxidase procedures were incubated
in 3% hydrogen peroxide and 10% methanol in PB 0.1 M to
quench endogenous peroxidase activity, prior to overnight incu-
bation with the primary antibody. Biotinylated secondary anti-
bodies were used (Table 2; 60 min incubation), along with the
avidin-biotin-complex (ABC) amplification method. The ABC
reagent was prepared according to manufacturer’s instructions
(Thermo Fisher Scientific, Waltham, MA, USA) and incubated
during 30 min. Peroxidase activity was revealed with 0.05% DAB
and 0.03% hydrogen peroxide. All the incubations were performed
in a moist chamber at RT.
To study the co-localization of particular markers, double
immunofluorescence was performed using the following pairs of
antibodies: ICAM1 and IBA1, IBA1, and IL1β, myeloperoxidase
(MPO) and IL1β, and CD3ε and CD8α. The primary antibodies
were mixed and incubated simultaneously (overnight at RT). Alexa
fluor secondary antibodies (Table 2) were used. Coverslides were
mounted with buffered glycerol containing 10% of the anti-fading
agent Mowiol 4-88 (Calbiochem/EMD Chemicals, San Diego, CA,
USA). The sections were then observed under a confocal micro-
scope (Leica, SP5 II). Some antibodies required specific antigen
retrieval pretreatment prior to immunostaining. Thus, the sections
incubated with anti-CD3ε and anti-CD8α were pretreated with
Table 1 | List of primary antibodies used for immunohistochemistry.
Antibody Inmunogen, expected target Manufacturer, species and type, catalog number Dilution
Anti-CD3ε C-terminus of mouse CD3ε, T-lymphocytes Santa Cruz, Dallas, TX, USA, goat IgG polyclonal, SC1127 1:200
Anti-CD8α Rat thymocyte membrane CD8α glycoprotein,
CD8+T-lymphocytes
Serotec, Oxford, UK, mouse IgG monoclonal, MCA48R 1:1500
Anti-GFAP GFAP from pig spinal cord, astrocytes Sigma, St Louis, MO, USA, mouse IgG monoclonal, G3893 1:1000
Anti-IBA1 Carboxy-terminal sequence of IBA1, microglia Wako. Osaka, Japan rabbit IgG polyclonal,19-19741 1:500
Anti-ICAM1 Rat ICAM1 CD54, vascular endothelial cells R&D Systems, Minneapolis, MN, USA, goat IgG polyclonal, AF583 1:40
Anti-IL1β E. coli-derived recombinant rat interleukin1β,
macrophagues
R&D Systems, Minneapolis, MN, USA, goat IgG polyclonal, AF501NA 1:200
Anti-LFA Agglutinin of the lectin Limax flavus, LFA A gift of Prof. E Rodríguez, rabbit IgG polyclonal 1:1000
Anti-MPO Myeloperoxidase from human granulocytes,
neutrophils
Abcam, Cambridge, UK, rabbit IgG polyclonal, ab9535 1:100
Anti-PAX5 C-terminus of human Pax-5 B-lymphocytes Santa Cruz, Dallas, TX, USA, goat IgG polyclonal, SC1974 1:200
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Table 2 | List of secondary antibodies used for immunohistochemistry.
Antibody Supplier, cat. number Dilution
Immunoperoxidase
Goat anti-mouse IgG
(biotinilated)
Pierce, Rockford, IL, USA,
31800
1:1000
Goat anti-rabbit IgG
(biotinilated)
Pierce, Rockford, IL, USA,
31820
1:1000
Horse anti-goat IgG
(biotinilated)
Vector, Burlingame, CA, USA,
VA9500
1:1000
Immunofluorescence
Rabbit anti-goat IgG
(Alexa 488)
Molecular Probes, Madrid,
Spain, A21222
1:1000
Goat anti-rabbit IgG
(Alexa 488)
Molecular Probes, Madrid,
Spain, A11070
1:1000
Donkey anti-mouse IgG
(Alexa 594)
Molecular Probes, Madrid,
Spain, A21203
1:1000
Donkey anti-rabbit IgG
(Alexa 594)
Invitrogen, Carlsbad, CA,
USA, A21207
1:1000
Donkey anti-goat IgG
(Alexa 488)
Invitrogen, Carlsbad, CA,
USA, A11055
1:1000
10 mM TRIS-EDTA buffer pH 9.0, and the sections incubated
with anti-PAX5 were pretreated with 10 mM citrate buffer pH
6.0. In both cases, pretreatment was done at 95°C in microwave
for 8 months.
QUANTITATIVE STUDIES
Two different strategies were used depending on the staining
properties of the cells or structures to be quantified. When the
quantified resident cells displayed processes or irregular shapes
(microglia, astrocytes, and endothelial cells) the immunostained
area was measured. If the cells had well-defined profiles easily
distinguishable from each other (infiltrating leukocytes), a direct
count of the number of cells was preferred.
Quantification of ICAM1, IBA1, and GFAP immunostaining
To study the response of the resident cells to NA-injection, we
quantified the area immunostained with ICAM1, IBA1, and GFAP
at different times (0, 4, 24 h, 7, and 15 days) after the inoculation of
NA. These times were determined after the qualitative observation
of the differences between the injected and the contralateral sides
over time.
A previous detailed study of immunostained serial sections
allowed the selection of the levels to be studied. Thus, two sections
from each animal (Bregma −0.3 and −0.92 mm approximately)
were chosen for the quantification. In any case, the selected
sections were close to the foramen of Monro but far enough from
the site of injection as to avoid areas of surgically damaged tis-
sue. In each section studied, micrographs were taken from the
striatal ventricular wall, and from the septum-fimbria wall, both
in the injected side and in the contralateral one (red squares in
Figure 2A show the approximate location of the micrographs).
Pictures were then processed using the image analysis software
Visilog 6.3 (Noesis, France). To introduce a correction related
to the basal level of expression of a particular marker in each
animal, the immunostained area measured in the contralateral
side was subtracted to the value obtained in the same location in
the injected side. This correction was made to subtract the basal
expression of a marker in each animal, which was found to vary
from rat to rat. Afterwards, the mean value was obtained from
the two locations and the two sections studied from each ani-
mal, which was considered the total stained area of that animal.
A total of five animals were analyzed in each time post-injection
studied.
Quantification of infiltrating leukocytes
Cell infiltration was evaluated by immunostaining with the
following antibodies: anti-MPO for neutrophils, anti-IL1β
for monocyte-macrophages, anti-CD3ε for T-lymphocytes,
anti-CD8α for cytotoxic T-lymphocytes, and anti-PAX5 for
B-lymphocytes. We realize that these substances could also be syn-
thesized by other cell types. However, presently and in agreement
to many researchers, these markers are used to identify these dif-
ferent kind of immunologic blood-borne cells with a high degree
of confidence. However, a low possibility exists that some cell does
not belong to the corresponding group.
Immunoreactive cells were counted in three different loca-
tions: (1) the choroid plexus within the injected ventricle; (2) the
meninges close to the optic chiasm; and (3) the zone around the
foramen of Monro containing large venules close to the origin of
the choroid plexus and the subfornical organ. Serial sections from
Bregma −0.85 to −1.13 mm approximately (the level of the fora-
men of Monro) were immunostained with each antibody. Four
sections per animal were selected for counting of positive cells.
Between three and five animals were studied in each time post
NA-injection. The times post-injection studied were the same as
those selected for ICAM1, IBA1, and GFAP quantification (0, 4,
24 h, 7, and 15 days). In the case of the choroid plexus, the area
occupied by this structure in each section studied was measured
with the Visilog 6.3 software; the number of positive cells counted
in this location was expressed per millimeter square of choroid
plexus. In the other two locations, the number of positive cells was
expressed per section.
Statistical analysis
Differences between times post-injection of NA were evaluated by
ANOVA (significance level of 0.05), followed by a Tukey post hoc
test with a level of significance of 0.05. The values measured at time
0 were considered the baseline. The software SPSS® Statistics 20
(IBM®) was used for this analysis. In the histograms, the existence
of significant differences between groups is indicated with differ-
ent letters. Thus, two bars labeled with the same letter means that
there is no significant difference between the two groups. Con-
versely, two bars labeled with different letters indicate that there is
a significant difference between them.
RESULTS
Animals were sacrificed immediately after the injection of NA
(T: 0 h), LFA lectin exhibited a negative halo (~400µm from
the ventricle surface) around the injected lateral ventricle and
the rostral third ventricle (Figures 1A,C). The ependymal sur-
face of the injected lateral ventricle showed no staining at
www.frontiersin.org March 2015 | Volume 2 | Article 14 | 3
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Granados-Durán et al. Neuraminidase, neuroinflammation, and myelin vacuolization
FIGURE 1 | Lectin histochemistry in NA-injected rat brains immediately
after the injection. (A,B) The site of injection is indicated with a red arrow in
(A). Note a LFA-negative and PNA-positive halo around the injected lateral
ventricle (i) and the third ventricle (IIIv) (double-headed arrow) but not the
contralateral ventricle (cl). (C–F) Details of the zones squared in (A,B) showing
the negative or positive halo (double-headed arrows). The squared areas are
shown in detail in the following pictures. (G–J) The surface of the ependymal
cells was LFA-negative (G) and PNA-positive (I) in the injected ventricle,
whereas it was LFA-positive (H) and almost PNA-negative (J) in the
contralateral ventricle. cc, corpus callosum; cl, contralateral ventricle; i,
injected lateral ventricle; s, striatum; sf, septum-fimbria; IIIv, third ventricle.
Sections in (A,C,D,G,H) were counterstained with hematoxilin–eosin.
all (Figure 1G). Conversely, the contralateral ventricle showed
no halo (Figures 1A,D) and a conspicuous staining of the
subependyma and the surface of the ependymal cells (Figure 1H).
On the contrary, when using PNA lectin (terminal galactose affin-
ity) a positive label was found in the subependyma of the injected
ventricle (Figures 1B,E) that was particularly intense in the surface
of the ependymal cells (Figure 1I). The walls of the contralat-
eral ventricle showed virtually no binding to PNA (Figures 1B,F),
and the surface of the ependymal cells was only feebly positive
(Figure 1J). After about a week, the ependymal cells that remained
in the ventricular lining of the injected ventricle recovered the
sialic acid and thus the LFA binding.
Control rats, which were injected with the vehicle, did never
present any sign of brain inflammation. Only the brain cortex at
the level of the needle path showed a few signs of local inflam-
matory reaction that spontaneously healed as observed in brains
examined at different times after the injection. No evidences of
inflammation were observed in the brain ventricles, the meninges
or the periventricular regions.
The elimination of sialic acid triggers a series of events resulting
in inflammation. Some responses depend on changes in resident
brain cells while others on infiltrating blood leukocytes. Therefore,
both cell populations were quantified afterwards.
NA INDUCES UPREGULATION OF IBA1, GFAP, AND ICAM1 IN
RESIDENT CELLS
In NA-injected animals, the immunoreactivity to IBA1 antiserum
increased notably in the affected periventricular zones (compare
Figures 2E,F). We quantified the differences in two selected regions
of the striatum and the fimbria-fornix at different post-injection
times. IBA1 was upregulated from early times after NA injection,
and the basal levels were recovered after about 2 weeks (Figure 2B).
A notable increase in IBA1 immunoreactivity was also evident in
the injected side in places located far from the site of injection, as
is the optic tract (Figure 2K).
GFAP staining in astrocytes of control rats (non-injected or
saline-injected) was as expected, with no staining detected in the
ependyma or the choroid plexus. As for IBA1, quantification of the
GFAP stained area was carried out in selected regions of the stria-
tum and the fimbria-fornix area of the injected ventricle relative to
the contralateral one. GFAP staining showed a higher expression
24 h after NA-injection, which further increased one week later. It
remained overexpressed even 2 weeks post-injection (Figure 2C).
The increase in immunoreactivity was clearly observed also in
other region such as the stria medullaris (compare Figures 2G,H).
Regions located farther from the site of injection also presented
increased GFAP expression in the injected side with respect of
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FIGURE 2 | (A) Panoramic view at the level of the foramen of Monro (fM) of
the brain of an animal sacrificed 12 h after NA injection (red arrow points
injection site). The tissue was immunostained with ICAM1. Note an increase
in the immunoreactivity in the vessels of the affected periventricular zones
(double-headed arrow) and the strong reactivity of the choroid plexus (cp) and
the surface of the ependymal cells (arrow). The red squares correspond
roughly to the zones used for quantification; some are detailed in (I,J).
(B–D) Quantification of the expression of IBA1, GFAP, and ICAM1 in the
periventricular area at selected times post-injection. Red squares in (A) point
approximately the areas where micrographs were taken in the striatum and
the septum. The values represented are the difference of stained area
between the injected lateral ventricle (i) minus de contralateral ventricle (cl).
The bars are the mean±SEM of five animals analyzed. Letters (a–c) on bars
indicate the absence (same letter) or presence (different letter) of a significant
difference between groups (α=0.05). (E,F) Immunoreactivity to IBA1 in the
periventricular region at the level of the septum-fimbria (sf) in the injected (i)
and the contralateral (cl) ventricles, 2 h after NA injection. (G,H) Details of
GFAP staining in the stria medullaris (sm) in the injected (i) and the
contralateral (cl) sides 12 h after the administration of NA. (I,J) Details [red
squares in (A)] of the immunoreactivity to ICAM1 in the septum-fimbria (sf)
subependymal parenchyma of the injected (i) and the contralateral (cl) sides
12 h after the injection of NA. Note the strong immunoreactivity of the
ependymal surface in both ventriculi. (K,L) Twenty-four hours after NA
injection, the optic chiasm (oc) beneath the third ventricle (IIIv) showed a
higher IBA1 and GFAP staining in the injected (i) than in the contralateral side
(cl). cl, contralateral ventricle; cp, choroid plexus; fM, foramen of Monro; i,
injected lateralventricle; sfo, subfornical organ; sm, stria medularis; sf,
septum-fimbria; oc, optic chiasm; IIIv, third ventricle.
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the contralateral one, a fact particularly evident in the optic tract
(Figure 2L).
In control rats, the wall of the large vessels of the meninges, the
choroid plexus, the subependyma around the foramen of Monro,
and the surface of the ependymal cells (especially of the choroid
plexus) were immunoreactive to ICAM1. Parenchymal capillaries
were virtually negative. Conversely, in the injected rats the wall of
the parenchymal vessels located in the subependyma of the affected
ventricles (up to ~400µm from the ventricle surface) became
ICAM1-immunoreactive (Figure 2A; compare Figures 2I,J). As
for IBA1 and GFAP, the changes in immunoreactivity to ICAM1
were quantified in the same selected zones of the lateral ventricle
wall. There was a progressive increase in immunoreactivity that
was evident 4 h after the injection and peaked at 24 h (Figure 2D).
ICAM1 expression decreased afterwards to reach control levels
after about 2 weeks.
In control rats, IBA1 stained epiplexus cells in the choroid
plexus and very few subependymal microglial cells (Figure 3A).
In the experimental animals, a quite striking observation was that
some IBA1-positive cells beneath the ependyma, seemed to pene-
trate between the ependymal cells even before the onset of blood
cell infiltration (Figure 3B and inset). In similar locations, IL1β-
positive cells could be found at early times after NA administration
(Figures 3C,D). Moreover, double immunostaining demonstrated
the existence of cells that were positive to both IBA1 and IL1β
(Figures 3E,F).
NA INDUCED EXTRAVASATION OF BLOOD LEUKOCYTES
The most noticeable observation after the ICV inoculation of
NA was the extravasation of leukocytes in the injected, but not
the contralateral side. From about 4 h after the injection, cel-
lular infiltration took place in large blood vessels located in
the meninges, choroid plexus, and subependymal parenchyma.
Extravasation in smaller vessels was infrequent. The extravasated
leukocytes penetrated the brain parenchyma directly from the
vessels passing through the blood–brain barrier, the pial barrier,
or the ependyma of the choroid plexus (Figure 4A) and of the
ventricle walls (Figures 4B,C,E). To identify the nature of infil-
trating cells, we used antibodies against MPO for neutrophils
(Figures 4C,D), IL1β for monocyte-macrophages (Figures 3F and
4B,D), CD3ε and CD8α for T-lymphocytes (Figures 5A–G), and
PAX5 for B-lymphocytes (Figures 5H–J). Some infiltrating cells,
seemingly of the macrophagic-monocyte lineage, also stained for
IBA1 (Figures 3E and 4A) and ICAM1 (Figures 4E–G). Dou-
ble immunostaining with anti-MPO and anti-IL1β (Figure 4D)
revealed no co-localization of these two markers, indicating that
the antibodies discriminate quite well between neutrophils and
macrophages. Moreover,no polymorphonucleated cell was stained
using anti-IL1β, IBA1 or ICAM1 at any time post-injection
(Figures 4A,B,F). It is likely that the monocyte-macrophage cells
may be recognized by the IBA1 antiserum. Moreover, some of
them (i.e., those that were activated) were also recognized by IL1β
and ICAM1 antibodies (Figures 4B,D,E–G).
Lymphocytes infiltrated from the same vessels that neu-
trophils and macrophages (Figure 5), crossed the choroid
plexus ependyma (Figures 5C,I), and invaded the ventricle
(Figures 5A,I), the meningeal spaces (Figures 5D,J), and the brain
parenchyma (Figures 5B,H). As revealed by double immunofluo-
resce using anti-CD3ε and anti-CD8α antibodies, most of them
were cytotoxic T-lymphocytes (Figures 5E–G). B-lymphocytes
FIGURE 3 | (A) IBA1-positive epiplexus and subependymal cells
(arrowheads) in a vehicle-injected specimen sacrificed immediately after
the injection. (B) Detail of the striatal (st) side of the injected lateral
ventricle (i) near the inferior sulcus of the lateral ventricle 2 h after the
injection. Note IBA1-positive cells over, beneath and among the
ependymal cells (arrow and inset). (C) Two hours after the injection of
NA, scattered IL1β-positive cells occurred inside (arrow) and outside the
choroid plexus (cp) as well as in the subependyma (arrowhead) of the
injected ventricle. (D) Detail of IL1β-stained cells in the subependyma
(arrowhead) and crossing the ependymal wall (arrow) of the third ventricle
(IIIv) 4 h after the injection of NA. (E,F) Double immunofluorescence with
anti-IBA1 (red) and anti-IL1β (green). Double-stained cells appear in the
ventricle and the subependyma (arrowheads, and merge detailed in the
inset of (F) showing a double-stained subependymal cell). Many
IBA1-positive cells in the brain parenchyma were not immunoreactive to
IL1β [arrow in (E)]. cp, choroid plexus; sf, septum-fimbria; sm, stria
medullaris; (i), injected lateral ventricle; st, striatal wall of the lateral
ventricle; f, fornix; IIIv, third ventricle.
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FIGURE 4 | (A) Infiltrating IBA1-positive cells in the choroid plexus (cp) of
the injected ventricle at 24 h post-injection. Polymorphonucleated cells
inside and outside the choroid plexus were never stained (arrows); positive
cells occurred inside (arrowhead) outside (open arrow), and in transit
(asterisk). (B) Twelve hours after NA injection, abundant IL1β-positive cells
were seen in the ventricle, penetrating the ependyma (arrowheads) and in
the brain parenchyma, in the septum-fimbria (sf) area. Polymorphonuclear
negative cells, present inside and outside choroid plexus (cp), the ventricle
and the parenchyma (arrows), were also numerous. (C) MPO
immunostaining in the region of the foramen of Monro, where positive
cells were found near the choroid plexus (cp), the ependyma (e), and
penetrating the brain parenchyma (arrows) in the region of the stria
medullaris (sm). (D) IL1β (green) and MPO (red) double
immunofluorescence in the region of the choroid plexus (cp) of the
injected ventricle 12 h after NA administration. No double-stained cells
were detected. (E) Detail of a zone of the foramen of Monro (fM)
comprising a part of the stria medullaris (sm) 12 h after the injection of NA,
immunostained with anti-NCAM1. The surface of the ependymal cells (e)
and of the choroid plexus (cp) and the wall of the local vessels (v) was
strongly stained. Some infiltrating cells in the ventricle (arrowheads) and in
the brain parenchyma (arrows) were also positive. (F) Detail of an
immunoreactive cell with lobed nucleus in the ventricle. The
polymorphonucleated leukocytes (arrows) were never immunoreactive to
ICAM1. (G) Some cells present in the ventricle were double-stained with
ICAM1 and IBA1 (open arrow). The ICAM1-positive surface of the
ependymal cells (e) can be observed, as well as some IBA1-positive
subependymal cells (arrowhead). cp, choroid plexus; sf, septum-fimbria; e,
ependyma; sm, stria medullaris; fM, foramen of Monro; v, vessels.
(PAX5-positive) were also present, but they were much less
abundant (about one-tenth) than T-lymphocytes (Figures 5H–J).
Infiltrating cells were counted at different post-injection times
in three selected locations (Figure 6): (i) the choroid plexus of
the injected ventricle (Choroid plexus in Figure 6); the contralat-
eral plexus showed virtually no activation; (ii) the zone around
the ipsilateral foramen of Monro, where large venules are found
(Vessels in Figure 6); (iii) the region of the meninges close to the
ipsilateral side of the optic chiasm (Optic chiasm in Figure 6).
Neutrophils were by far the most numerous infiltrating cells,
followed by T-lymphocytes and monocyte-macrophages, while
B-lymphocytes were the least abundant. The choroid plexus was
the richest source of blood cells, followed by the large vessels in the
meninges and those around the foramen of Monro. The meningeal
vessels, although situated far from the site of injection (i.e., the
optic chiasm) were quite reactive.
Regarding the time course of infiltration, the earliest events
were the invasion of neutrophils (MPO-positive; Figures 4C,D)
and macrophages (IL1β-positive; Figures 4B,D), which reached a
maximum only 4 h after the inoculation of NA; at 24 h these cells
were already clearing (Figure 6). Lymphocytes (CD3ε-positive;
Figures 5A–D) appeared later, and peaked at about 24 h (Figure 6).
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FIGURE 5 | CD3ε, CD8α, and PAX5 immunostainings. (A–D) CD3ε
staining in the zone of the foramen of Monro (fM) of the injected ventricle
comprising a part of the stria medullaris [sm, (A)]. Many positive cells
occurred in the perivascular spaces of the local large venules 12 h after NA
injection. A detailed view (B) of the vessels in the stria medullaris (sm)
shows that many positive cells have smooth nuclei while
polymorphonucleated cells (arrow) are negative. (C) Twenty-four hours
after the injection, some positive cells seemed to cross the ependyma of
the choroid plexus (cp). (D) Positive cells were also present in the
meninges (men) next to the optic chiasm (oc), and few appeared to
penetrate the brain parenchyma (arrow). (E–G) Double
immunofluorescence of lymphocytes in a 12 h post-injection brain section.
Most CD3ε-positive cells [(E), green] found in the perivascular spaces of
the large vessels were also positive for CD8α [(F), red]. (H–J) PAX5
immunostaining showing positive cells in the wall of the large vessels
around the foramen of Monro [fM; (H)], although they were not as
abundant as CD3ε-positive cells. Few PAX5-positive nuclei were also found
in the choroid plexus (cp) of the injected lateral ventricle (I) as well as in the
meninges (men) close to the optic chiasm [oc; (J)]. cp, choroid plexus; fM,
foramen of Monro; men, meninges; oc, optic chiasm; sm, stria medullaris.
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FIGURE 6 | Quantification of MPO, IL1β, CD3ε, and PAX5 immunostained
cells. The quantification was done in three different locations (indicated by red
squares in the coronal section diagrams): (i) the choroid plexus of the injected
lateral ventricle, (ii) the area comprising large vessels close to the foramen of
Monro and near the subfornical organ (Vessels), and (iii) the zone of the
meninges and the optic chiasm. Most of the cells stained and counted were
infiltrating cells. MPO- and IL1β-positive cells (neutrophils and macrophagic
cells, respectively) reached a maximum before 24 h. The peak of CD3ε and
PAX5-positive cells (probably T- and B-lymphocytes) occurred later, and these
cells remained longer (even up to 15 days) in some locations. The bars
represent the mean±SEM of five animals. Letters (a–c) on bars indicate the
absence (same letter) or presence (different letter) of a significant difference
between groups (α=0.05). Time 0 post-injection of NA (0 h) is considered the
baseline population of positive cells.
In the choroid plexus, these cells were more persistent and
remained for up to 2 weeks.
DISCUSSION
The present work describes a novel model of neuroinflamma-
tion based on the ICV administration of the enzyme NA, which
specifically removes terminal sialic acid from carbohydrate chains.
This model intends to demonstrate that the NA activity from
brain-targeting pathogens might result in pleiotropic inflamma-
tory changes. The events that follow NA administration closely
resemble those of an inflammatory process, and could be divided
into phases. The phase 1 comprises the first 4 h after injection;
the events that take place during this period are (a) the cleavage
of sialic acid from the ependymal surface and the periventricular
parenchyma, (b) the detachment and death of a fraction of the
ependymal cells; and (c) the response of resident cells such as ven-
tricular macrophages, microglia, astrocytes and endothelial cells of
the vessels. The phase 2 starts about 4 h after NA injection. Extrava-
sation of leukocytes occurs from certain brain vessels, resulting
in the invasion of the affected zones in an ordered sequence of
neutrophils, macrophages, and lymphocytes. These cells invade
mostly the ventricles, the meninges, and can even penetrate the
brain parenchyma in the affected regions.
TOXICITY OF NEURAMINIDASE
The enzyme NA from C. perfringens used in the present inves-
tigation contains <0.1% of unspecific contaminating protease
activity. Thus, we think that the effects described may be mostly
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attributable to the specific cleavage of sialic acid. Moreover, we did
also inject NA from other sources, named the bacteria Arthrobac-
ter ureafaciens, the Newcastel virus, and the influenza virus and
obtained similar results. The lectin study demonstrated that the
NA from C. perfringens cleaves sialic acid and exposes galactose
residues from the ependyma and the subependymal parenchyma
to a depth of about 400µm. The desialyzation affects the injected
ventricle and (at least) the rostral part of the third ventricle but not
the contralateral ventricle. In previous studies using a higher dose
of NA (10), desialyzation extended up to the level of the foramina
in the fourth ventricle. In this location, NA seems to escape from
the ventricle toward the outer CSF compartments. By this route,
the NA could exert its effects in the meninges and in places located
farther from the injection site such as the optic tract.
Many microbes that provoke ependymal detachment, inflam-
mation, and hydrocephalus posses NA in their envelopes (14, 23,
24). Kelly and Greiff (11, 12) demonstrated in mice the high toxic
effects of bacterial and viral NA when injected directly into the
brain. Also, in humans, NA activity seems to be associated with
adverse prognosis in pneumococcal meningitis (13). So much so
that mump viruses with low neurovirulence due to point muta-
tions in hemagglutinin–neuraminidase capside proteins are being
used to develop new harmless vaccines (15). Thus, it seems that
the sole presence of NA in the CSF may trigger inflammation that
gives rise to important brain damages.
ACTIVATION OF RESIDENT CELLS
The activation of microglia, astrocytes, and endothelial vascular
cells after the administration of NA was studied. IBA1 and GFAP,
used here to identify microglia and astrocytes, respectively, are
known to increase its expression after brain insults (25–27). The
increase in IBA1 expression could be related to a higher mobility of
microglia (28, 29). In this sense, we observed many IBA1-positive
cells crossing the ependymal barrier after NA treatment and before
the invasion of the brain by blood-borne cells. Interestingly, many
of these cells also expressed IL1β, as observed by double immunos-
taining. Furthermore, we did not see any IL1β-positive cell in
control specimens. This suggests that some IBA1-positive resi-
dent subependymal cells might have acquired IL1β positivity after
the injection of NA, and that they move toward the lumen of the
ventricle through the ependymal lining. However, since the ven-
tricular macrophages (i.e., epiplexus cells in the choroid plexus)
also expressed IBA1 and, after NA insults, begun to express IL1β,
we do not have the definitive evidence to know whether the cells
crossing the ependyma are indeed subependymal microglia or ven-
tricular macrophages. IL1β is a known inflammatory mediator of
the monocyte–macrophagic cell lineage (30). The capability of
microglia to release IL1β was reported before in a variety of brain
insults (31–33). It is likely that the increased expression of IBA1
and IL1β is related to the posterior pleocytosis, and reflects a tight
relationship between the subependymal microglia and the resi-
dent ventricular macrophages. In this sense, both cell types share
a common ontogenetic origin (34, 35) and may serve as sentinels
of the ventricular system, probably acting as an important first-
line defensive barrier to a variety of brain insults. It has been
recently shown that may exists at least two subsets of microglial
cells capable of increase the expression of IBA1 after experimental
insults (36), one in the acute phase and the other in the chronic
phase. We agree that different populations of microglial cells, as
for macrophages, may play different roles in neuroinflammation
after traumatic injuries. This subject deserves future investigation
in our model too.
Regarding the increased expression of GFAP, the activation of
astrocytes in those places more affected by the NA could be associ-
ated to the formation of a glial scar that takes place after ependymal
denudation (20, 37). However, in structures located relatively far
from the site of the injection, such as the stria medullaris or the
optic chiasm, the activation of astrocytes and microglia is most
probably related to the neuroinflammation process. It is quite
evident that microglia and astrocytes play active roles in neuroin-
flammation but the exact mechanism of action is still controversial
(38, 39).
ICAM1 is a key player in the recruitment of leukocytes during
inflammation (40, 41). Its expression is increased in endothelial
cells of vessels located in brain regions affected by an inflammatory
insult (42–47). We also found a significant increase in the expres-
sion of ICAM1 in the cerebral blood vessels located within the
regions affected by the injection of NA. In agreement to Alvarez
and Teale (48), the vessels displaying a more prominent extrava-
sation were the venules of the leptomeninges, the choroid plexus
and the subependyma around the injected lateral ventricle and the
foramen interventricularis. These same vessels showed the higher
expression of ICAM1, which was detectable even in control non-
injected specimens. Interestingly they also presented the highest
expression of receptors for IL1β (49) and for other inflammatory
mediators (44). This suggests that inflammatory mediators, such
as IL1β, might preferentially elicited extravasation in these vessels.
The functional relevance of the different permeability of parenchy-
mal vessels versus large meningeal, choroidal, and subependymal
vessels is still an open question (48, 50). On the other hand, ICAM1
was also expressed in the surface of the ependymal cells (especially
in the choroid plexus) and of some ventricular cells. This could
speak in favor of a role of ICAM1 in the penetration of some
invading cells into the brain parenchyma (51–53).
INFILTRATION OF BLOOD LEUKOCYTES
In the model here described a profuse invasion of white blood cells
takes place from about 4 h after the NA-injection. The time course
of such neuroinflammation was similar to that of other models in
rodents (23, 54–56). The first extravasated cells were neutrophils,
followed by macrophages and then lymphocytes. In agreement
to Ma et al. (57), most lymphocytes were T-lymphocytes (CD3ε-
positive) and of these most were CD8α-positive, as occurred in
other cases of brain inflammation (58). The leukocytes crossed
both the blood–brain barrier and the blood–CSF barrier, and
invaded the perivascular spaces and the ventricular or meningeal
CSF (59). They also reached the brain parenchyma, either directly
from vessels located in the parenchyma or from the ventricle after
crossing through the ventricular ependyma. The production by the
invading or the resident cells of metalloproteinases that degrade
specific junctional proteins seems to be essential for the invasion
process (60). The passage of cells (resident or infiltrative) through
the ependymal lining is still an unresolved question (61, 62) and it
should also require the production of metalloproteinases (63–65).
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The nature of the signals involved in this trafficking of cells, the
fate of the amoeboid cells, and the consequences in the periven-
tricular tissues are still not well understood and deserve future
investigations.
In summary, we describe here a novel model, compatible with
life, to study the time course of aseptic meningitis and ventriculitis
in rodents. The pathology, which is induced by the ICV injec-
tion of the enzyme NA, is highly reversible, and rats cure almost
completely after some weeks. Apparently, only minor long last-
ing consequences remain in certain zones, mostly nearby the site
of injection. However, these minor consequences could make the
NA-treated animals more prone to develop neurological disorders,
a possibility that deserves further research.
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